Skip to search formSkip to main contentSkip to account menu

HP 029

Known as: HP-029 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

velnacrinevelnacrine maleate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
HP-029-2 大腸pSM癌の術後再発例の検討(大腸(SM大腸癌治療2),ハイブリッドポスター,第109回日本外科学会定期学術集会)
1993
1993
EEG-Mapping bei Alzheimer Patienten unter Behandlung mit Velnacrine (HP-029)
Bei Patienten mit einer Demenz vom Alzheimer Typ werden typische EEG Befunde beschrieben [1], die sich unter der Gabe von… 
1992
1992
Membrane-altering effects of velnacrine and N-methylacridinium: relevance to tacrine and Alzheimer's disease.
1991
1991
Evaluation of HP 029 (Velnacrine Maleate) in Alzheimer's Disease a
HP 029 (1,2,3,4-tetrahydro-9-aminoacridin-1-ol-maleate) is a cholinesterase inhibitor and one of a series of compounds… 
1990
1990
Clinical Safety, Tolerance, and Plasma Levels of the Oral Anticholinesterase 1,2,3,4‐Tetrahydro‐9‐aminoacridin‐1‐oL‐maleate (HP 029) in Alzheimer's Disease: Preliminary Findings
HP 029 (1,2,3,4‐tetrahydro‐9‐aminoacridin‐1‐oL‐maleate), an oral anticholinesterase, enhances memory in rodents and may be useful… 
1990
1990
Multiple Dose Pharmacokinetics, Safety, and Tolerance of Velnacrine (HP 029) in Healthy Elderly Subjects: A Potential Therapeutic Agent for Alzheimer's Disease
The pharmacokinetics, safety, and tolerance of 1,2,3,4‐tetrahydro‐9‐aminoacridin‐1‐ol‐ maleate (HP 029) a potential therapeutic… 
1990
1990
Pharmacological and biochemical assessment of SM-10888, a novel cholinesterase inhibitor.
The effects of the compound SM-10888 (9-amino-8-fluoro-1,2,3,4-tetrahydro-2,4-methanoacridine citrate) in a number of… 
1990
1990
Effect of a novel CNS-selective cholinesterase inhibitor, SM-10888, on habituation and passive avoidance responses in mice.
The effects of the tacrine (THA) derivative SM-10888 (9-amino-8-fluoro-1,2,3,4-tetrahydro-2,4-methanoacridine citrate) on… 
Highly Cited
1989
Highly Cited
1989
9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.
The synthesis of a series of 9-amino-1,2,3,4-tetrahydroacridin-1-ols is reported. These compounds are related to 1,2,3,4… 
1989
1989
The Effect of Food on the Bioavailability of Velnacrine (HP 029) in Healthy Elderly Men: A Potential Alzheimer Agent
Velnacrine (HP 029; 1,2,3,4‐tetrahydro‐9‐aminoacridin‐1‐ol‐maleate) is an investigational drug being studied in patients with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)